ADMA Biologics Inc (ADMA): Price and Financial Metrics

ADMA POWR Grades

• Growth is the dimension where ADMA ranks best; there it ranks ahead of 83.22% of US stocks.
• The strongest trend for ADMA is in Value, which has been heading down over the past 179 days.
• ADMA's current lowest rank is in the Quality metric (where it is better than 0.32% of US stocks).

ADMA Stock Summary

• ADMA has a higher market value than 30.38% of US stocks; more precisely, its current market capitalization is $358,534,246.
• Revenue growth over the past 12 months for Adma Biologics Inc comes in at 91.72%, a number that bests 91.07% of the US stocks we're tracking.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for ADMA comes in at -33.78% -- higher than that of only 11.86% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Adma Biologics Inc are ACB, TTMI, BCOR, IDXG, and CMCO.
• ADMA's SEC filings can be seen here. And to visit Adma Biologics Inc's official web site, go to www.admabiologics.com.

ADMA Valuation Summary

• ADMA's price/sales ratio is 3.1; this is 18.42% lower than that of the median Healthcare stock.
• ADMA's EV/EBIT ratio has moved up 2.2 over the prior 96 months.
• Over the past 96 months, ADMA's price/sales ratio has gone down 41.8.

Below are key valuation metrics over time for ADMA.

ADMA Growth Metrics

Its 4 year net income to common stockholders growth rate is now at -186.96%.
• Its year over year net cashflow from operations growth rate is now at -27.77%.
• Its 5 year revenue growth rate is now at 361.89%.

Over the past 67 months, ADMA's revenue has gone up $60,717,432.

The table below shows ADMA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	68.51584	-111.1232	-74.40597
2021-06-30	58.11165	-121.5629	-73.61047
2021-03-31	48.06866	-110.5851	-74.88326
2020-12-31	42.21978	-102.003	-75.74855
2020-09-30	40.30074	-89.43556	-66.9018
2020-06-30	37.24689	-89.2138	-61.42281

ADMA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ADMA has a Quality Grade of F, ranking ahead of 0.06% of graded US stocks.
• ADMA's asset turnover comes in at 0.268 -- ranking 168th of 682 Pharmaceutical Products stocks.
• NOVN, ARNA, and ZYNE are the stocks whose asset turnover ratios are most correlated with ADMA.

The table below shows ADMA's key quality metrics over time.